ARTICLE | Company News
Chugai, Kowa, Sanofi deal
November 23, 2015 8:00 AM UTC
Kowa and Chugai expanded a 2012 deal to develop Chugai’s diabetes drug Deberza tofogliflozin hydrate in Japan. Chugai now granted Kowa exclusive rights to develop and commercialize the sodium-glucos...